- Home
- BBNX vs GBLI Comparison
BBNX vs GBLI Comparison
Compare BBNX & GBLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBNX | GBLI |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.1M | 398.7M |
| IPO Year | 2025 | 2010 |
Fundamental Metrics
Financial Performance| Metric | BBNX | GBLI |
|---|---|---|
| Price | $18.08 | $28.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $23.80 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 4.3K |
| Earning Date | 04-21-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 5.13% |
| EPS Growth | ★ 78.95 | N/A |
| EPS | N/A | ★ 1.05 |
| Revenue | $100,251,000.00 | ★ $450,098,000.00 |
| Revenue This Year | $34.90 | $14.23 |
| Revenue Next Year | $34.63 | $9.68 |
| P/E Ratio | ★ N/A | $26.69 |
| Revenue Growth | ★ 53.94 | 2.02 |
| 52 Week Low | $8.80 | $24.28 |
| 52 Week High | $32.71 | $30.52 |
Technical Indicators
Market Signals| Indicator | BBNX | GBLI |
|---|---|---|
| Relative Strength Index (RSI) | 63.68 | 57.19 |
| Support Level | $9.34 | $27.45 |
| Resistance Level | $18.20 | $28.98 |
| Average True Range (ATR) | 1.31 | 0.57 |
| MACD | 0.31 | 0.06 |
| Stochastic Oscillator | 95.44 | 71.66 |
Price Performance
Historical ComparisonAbout BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
About GBLI Global Indemnity Group LLC (DE)
Global Indemnity Group LLC is a United States-based holding company with a diversified portfolio of property and casualty insurance-related entities. Along with its subsidiaries, the company operates in the following reportable segments: Agency and Insurance Services, Belmont Insurance Companies - Core (Belmont Core), and Belmont Insurance Companies - Non-Core (Belmont Non-Core). Maximum revenue is generated from the Belmont Core segment, which offers direct insurance and assumed reinsurance products in the E&S (Excess and Surplus) marketplace. The Agency and Insurance Services segment is focused on sourcing, underwriting, and servicing primary and assumed reinsurance business; and specialized insurance service businesses providing technology, AI-enabled marketplace, and claims services.